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Widespread and overuse of antibiotics are associated with antibiotic resistance and loss of microbiota. Furthermore, studies have shown that prolonged 
duration of empiric antibiotic therapy for early-onset sepsis 
(EOS) has been associated with increased risk of death and 
necrotizing enterocolitis. In addition, overuse of antibiotics can 
cause adverse events such as nephrotoxicity, hepatotoxicity, and 
hematological abnormalities. For these reasons, asymptomatic 
neonates at birth with risk factor for EOS should have minimal 
exposure to antibiotics [1].
Identification of early neonatal sepsis is a major issue 
due to limitations in diagnostic procedures and severity of the 
outcome. The gold standard of positive blood culture has very 
low sensitivity [1]. The incidence of preterm births (<37 weeks 
gestation) is increasing in many countries around the world and has 
become a global health concern. More than 70% of preterm infants 
are born between 34 and 36 weeks of gestation [2]. Minimizing 
antibiotic exposure among these groups of infants without risk 
is not an easy task. Different screening tests and combination 
of tests including acute-phase reactants, hematological scoring 
systems, and recently cytokines are used for the identification of 
early-onset neonatal sepsis (EONS) and the optimal selection of 
which is yet to be determined; cost can also be limiting. Good 
negative predictive values can be obtained at 12–24 h of life 
(99%) with C-reactive protein (CRP) [3-5].
Infants hospitalized in neonatal intensive care units (NICUs) 
are commonly prescribed antibiotics. As evidence, in a point 
prevalence study of 29 NICUs, 47% of 827 infants were receiving 
at least one antibiotic on the day of the survey [1]. Antibiotics 
are frequently initiated for suspected infection, particularly in low 
birth weight infants [6]. Biomarkers may be useful to identify 
infants with true infection and reduce unnecessary antibiotic 
use. In a multicenter study, Franz et al. assessed the impact of 
measuring interleukin-8 and CRP versus CRP alone on the 
initiation of empiric antibiotics for EOS and found that the use of 
both biomarkers and CRP alone decreased antibiotic use (49.6% 
vs. 36.1%; p<0.0001), and there was not an increase in missed 
infections [7].
In this study, we hypothesize that the use of antibiotics in late 
preterms who are asymptomatic but with maternal risk factor 
(preterm prelabor rupture of membrane [pPROM]) and preterm 
onset of labor (PTOL) for EOS and in symptomatic neonates but 
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without maternal risk factor for sepsis can be optimized by not 
initiating antibiotic at birth.
METHODS
This descriptive study was conducted in a tertiary care center, 
located in Trivandrum, Kerala. The hospital is recognized for 
undergraduate and postgraduate training courses under MCI. All 
late preterm (34+0–36+6 weeks) babies with and without maternal 
risk factor for EOS, and with and without symptoms at birth, 
delivered in our hospital during the study period (from April 2016 
to March 2017) were included in the study. Gestational age of the 
study neonates was confirmed with early ultrasound done during 
the first trimester of pregnancy and in those babies with the 
unavailability of early antenatal ultrasound, New Ballard scoring 
was done to assess their gestational age. The cause of prematurity 
of our study neonates are: PTOL, pPROM, severe pregnancy 
induced hypertension, placenta previa, abnormal Doppler, 
abruptio placentae, severe oligohydramnios, Indirect Coomb’s 
Test positive, previous caesarian section, breech presentation and 
twin gestation.
All late preterm neonates (34+0–36+6 weeks) who are 
asymptomatic at birth with and without maternal risk factor for 
EOS at birth were subjected to clinical assessment of the following: 
Sensorium, temperature, oxygenation status assessed by the 
presence of respiratory distress (Downes score), and requirement 
of oxygen for maintaining saturation (to keep SpO2 91–95%), 
perfusion assessed by capillary filling time and skin color, starting 
after 1 h of initial stabilization till discharge from hospital. Sepsis 
screen (CRP and absolute neutrophil count [ANC]) was obtained 
at 24 h and 48 h of age from these asymptomatic late preterms.
Only those babies who had positive sepsis screen or 
abnormal clinical findings on observation were initiated on 
antibiotics – injection ampicillin and gentamicin after obtaining 
blood culture (using BacT/Alert FA microbial detection system). 
The doses and frequencies of antibiotics were adjusted to 
gestational age and postnatal age as per the neonatal drug 
formulary. Antibiotics were stopped with negative sepsis screen 
and negative blood culture at 48–72 h. None of our symptomatic 
babies required inotropic or ventilator support while three 
babies required short period of non-invasive ventilation. All late 
preterms, who remained asymptomatic during the hospital stay 
and not initiated on antibiotics, were followed up for 1 month 
age for any readmission to hospital requiring intravenous (IV) 
antibiotic with suspect late-onset sepsis.
Late preterm neonates (34+0–36+6 weeks) who were 
symptomatic at birth with and without maternal risk factor for 
EOS were initiated on antibiotic at birth after obtaining blood 
culture. Symptoms at birth were defined as the presence of 
tachypnea (respiratory rate >60/mt), chest retractions, grunting, 
requiring oxygen through hood or respiratory support, and poor 
tone and poor activity developed within 4 h of birth.
The study was conducted for 12 months period, so the total 
number of late preterms delivered during this study period was 
included for analysis. The data were entered into the Microsoft 
Excel sheet and the results were analyzed descriptively using 
the SPSS statistics version 19. The probabilities of developing 
late-onset sepsis in those asymptomatic babies and the rate of 
risk increase in the onset of symptoms in neonates exposed to 
maternal risk factor for sepsis were calculated.
RESULTS
In this descriptive study, 135 late preterm neonates 
(34+0–36+6 weeks) recruited during the study period were included 
for analysis. Mean gestational age of the study population was 
36 weeks and the mean birth weight was 2340 g. Table 1 shows 
the cause of prematurity of the study neonates. A total of 116 
neonates (86%) were asymptomatic at birth and not initiated on 
IV antibiotics. Among those 116 asymptomatic babies, 38 babies 
(33%) were exposed to maternal risk factor (pPROM and/or 
PTOL) for sepsis and not received IV antibiotics. Serial sepsis 
screen at 24 and 48 h of age and the blood culture were negative 
in all babies. Five babies were lost to follow-up and remaining 111 
asymptomatic babies were followed up for 1 month, they were 
clinically remained well and not required hospital admissions 
necessitating IV antibiotics during the neonatal period.
Of 135 neonates, 19 (14%) were symptomatic at birth. Among 
those 19 symptomatic babies, only 8 babies (42%) were exposed 
to maternal risk factor (pPROM and/or PTOL) for sepsis and 
11 (58%) babies were not exposed to maternal risk factor for 
sepsis, but all babies were initiated on IV antibiotics as they were 
symptomatic (Table 2). Serial sepsis screening and blood culture 
were negative in all those symptomatic babies, but antibiotics 
continued for 3–5 days until babies were clinically well. None 
of those symptomatic babies required inotropic support. 58% of 
symptomatic babies who were not exposed to maternal risk factor 
for sepsis received unnecessary antibiotics, even though their 
sepsis screening and blood culture were negative.
On estimating, the rate of onset of symptoms at birth, in neonates 
exposed to maternal risk factor for EOS, has shown no statistical 
Table 1: Cause of prematurity of the study neonates
Cause of prematurity Number
Preterm onset of labor 31
pPROM 18
Fetal distress 17
Previous cesarean section 19
Severe PIH 15
Twin gestation 13
Placenta previa 4
Severe oligohydramnios 3
Breech presentation 2
Abruption placenta 1
Abnormal Doppler 1
ICT positive (1:128) 1
pPROM: Preterm prelabor rupture of membranes, PIH: Pregnancy-induced 
hypertension, ICT: Indirect Coombs test
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significance in relation to the presence of symptoms at birth odds 
ratio (OR) 0.66, 95% confident interval (CI) (0.24–1.8) p=0.42.
DISCUSSION
EOS remains a serious and potentially fatal illness. Laboratory 
tests alone are neither sensitive nor specific enough to guide 
EOS management decisions. Assessing term and late preterm 
infants for risk of EOS are one of the most common clinical tasks 
conducted by pediatric providers [8]. In sick babies, we are posed 
to treat suspect or proven infection. However, the vast majority of 
newborn babies who are given antibiotics do not have infection. 
Widespread use of broad-spectrum antibiotic has been associated 
with the development of multidrug-resistant Gram-negative 
bacilli and invasive candidiasis [1]. Sepsis screens are mainly 
focused on babies who have no symptoms or signs of infection 
but have risk factors for EOS which are not sufficiently severe 
to prompt immediate treatment with antibiotics. The purpose 
of sepsis screen is to distinguish between babies who require a 
course of antibiotic treatment because the infection is likely or 
definitely present and in those in whom infection can be ruled 
out [1].
Puopolo et al., the American Academy of Pediatrics committee 
on infectious diseases, currently suggested three approaches for 
the use of risk factors to identify infants who are at increased 
risk of EOS [9]. Considering maternal risk factor threshold 
values alone, to identify infants at increased risk of EOS, results 
in overuse of empirical antibiotics [9]. Researchers at a center in 
Italy reported a cohort of 7628 term infants, who were managed 
with a categorical approach (maternal risk factor threshold values 
alone) to risk identification. The outcomes were then compared 
with a cohort of 7611 infants who were managed with serial 
physical examinations of the infant every 4–6 h through 48 h of 
age. Significant decreases in the use of laboratory tests, blood 
cultures, and empirical antibiotic agents were observed in the 
second cohort. Two infants who developed EOS in the second 
cohort were identified as they developed signs of illness [10]. The 
primary advantage of this approach is a significant reduction in 
the rate of antibiotic use.
In our study, we could observe that, if infants were managed 
based on maternal risk factor alone, it will result in increased use of 
antibiotics. Furthermore, maternal risk factor for EOS has shown 
no relation with increase in the presence of symptoms at birth, 
although it is not statistically significant in this study (OR 0.66, 
95% CI: 0.24–1.8). It has been suggested that pediatric providers 
should conduct serial clinical evaluations on all newborn infants 
without regard to the risk of EOS.
According to Puopolo et al. [9], a third strategy consists of the 
reliance on clinical signs of illness to identify infants with EONS. 
Under this approach, regardless of any estimation of neonatal or 
maternal risk factors for EONS, infants who appeared to be ill at 
birth and those who developed signs of illness over the first 48 h 
after birth are either treated empirically with antibiotic agents or 
further evaluated by laboratory screening. Among term and late 
preterm infants, good clinical condition at birth is associated with 
a reduction in risk for EOS of approximately 60–70% [11,12]. 
A multidisciplinary panel sponsored by Eunice Kennedy Shriver 
National Institute of Child Health and Human Development 
advocated that infants be flagged for risk of EOS on the basis 
of the obstetric diagnosis of suspected intra-amniotic infection 
but that those conducting newborn evaluation primarily should 
rely on clinical observation alone for well-appearing term and 
late preterm infants [13]. The limitation to this study was the 
small sample size and a study with considerably larger sample 
size is suggested for comprehensive outcome. In this study, we 
could observe that even in symptomatic babies with and without 
maternal risk factor for sepsis, none of the babies had positive 
blood culture (gold standard). Furthermore, the presence of 
negative serial sepsis screen (combination of CRP and ANC) 
along with baby remaining clinically well increased the negative 
predictive value and helped us to rule out the infection and not 
missed any infection.
CONCLUSION
In our study, as maternal risk factor for sepsis has shown no 
statistical significance for the presence of symptoms at birth, 
antibiotics use can be restricted to only those babies who have 
clinical worsening over 24–48 h of observation and/or along with 
supportive evidence of positive sepsis screen and/or blood culture, 
irrespective of the presence or absence of maternal risk for sepsis. 
For strong recommendation, the study has to be conducted with 
large sample size.
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